NCT03232190

Brief Summary

The main purpose of the neonatal intensive care unit (NICU) is to optimize the development of the newborn. Preterm children are at greater risk for developmental disorders. On the one hand, this is due to cerebral complications inherent to the prematurity, on the other hand it is related to the very early and therefore vulnerable stage of brain development at the time of the premature birth. The development of the child is also the result of a constant interaction between the infant and its environment, primarily the primary caregiver (i.e. the parents). A premature birth can cause great stress to parents, and there are several obstacles that can make it difficult to handle their child. Therefore, we have developed a web application that supports parents until their child reaches the age of two. By keeping them informed, we hope to make them more confident in their role as parents, and thus facilitate the parent-child interaction. In order to determine whether this form of support has an additional effect on the development of the premature child, we compare two groups of premature infants and a group of non-premature infants.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

February 16, 2017

Completed
5 months until next milestone

First Posted

Study publicly available on registry

July 27, 2017

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

July 31, 2019

Status Verified

July 1, 2019

Enrollment Period

8.9 years

First QC Date

February 16, 2017

Last Update Submit

July 30, 2019

Conditions

Keywords

prematuritypsychomotor developmentparent empowermente-healthparental supportpost discharge follow-up

Outcome Measures

Primary Outcomes (4)

  • Change in Bayley-III-NL

    Bayley Scales of Infant and Toddler Development Mental, social and motor development of the child

    5 months, 1 year, 2 year

  • Change in DT-P

    Distress Thermometer for Parents

    2 weeks after birth, 37 weeks PMA, 5 months, 1 year, 2 year, 5 year

  • Change in EMPO

    Dutch Empowerment Questionnaire Parental empowerment in raising children (intrapersonal, interactional, and behavioral)

    2 weeks after birth, 37 weeks PMA, 5 months, 1 year, 2 year, 5 year

  • WPPSI-III-NL

    Wechsler Preschool and Primary Scale of Intelligence Cognitive Development of the Child

    5 year

Secondary Outcomes (1)

  • Change in PNAR

    2 weeks after birth, 37 weeks PMA, 5 months, 1 year, 2 year, 5 year

Study Arms (3)

INTNIC

EXPERIMENTAL

NICU Intervention Group Web Application Infants \< 32 weeks

Other: Web Application

CNIC

NO INTERVENTION

NICU Control Group No Web Application Infants \< 32 weeks

CMAT

NO INTERVENTION

Maternity Unit Control Group No Web Application Infants \> 37 weeks

Interventions

Parents receive a web application that offers information and support until the age of 2.

INTNIC

Eligibility Criteria

AgeUp to 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Premature birth (\< 32 weeks)

You may not qualify if:

  • The lack of internet access or a personal email account
  • Little or no knowledge of Dutch in both parents
  • Children with a congenital disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ziekenhuis Oost-Limburg, Schiepse Bos 6

Genk, Limburg, 3600, Belgium

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Marie-Rose Van Hoestenberghe, MD.

    Ziekenhuis Oost-Limburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marie-Rose Van Hoestenberghe, MD.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neonatologist

Study Record Dates

First Submitted

February 16, 2017

First Posted

July 27, 2017

Study Start

January 1, 2014

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

July 31, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations